etoposide has been researched along with vosaroxin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chiba, K; Kashimoto, S; Sato, Y; Shibamori, K; Tomita, K; Tsuzuki, Y | 1 |
| Arkin, MR; Byl, JA; Conroy, A; Fox, JA; Hawtin, RE; McDowell, RS; Nguyen, T; Osheroff, N; Stockett, DE; Yang, W | 1 |
2 other study(ies) available for etoposide and vosaroxin
| Article | Year |
|---|---|
Synthesis and structure-activity relationships of novel 7-substituted 1,4-dihydro-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acids as antitumor agents. Part 2.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Drug Screening Assays, Antitumor; Humans; Mice; Naphthyridines; Neoplasm Transplantation; Stereoisomerism; Structure-Activity Relationship; Thiazoles; Transplantation, Heterologous; Triazoles | 2004 |
Voreloxin is an anticancer quinolone derivative that intercalates DNA and poisons topoisomerase II.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; DNA; DNA Damage; DNA Fragmentation; DNA Topoisomerases, Type II; Drug Delivery Systems; Etoposide; G2 Phase; Humans; Intercalating Agents; Naphthyridines; Quinolones; Thiazoles | 2010 |